- Home
- NHTC vs ESLA Comparison
NHTC vs ESLA Comparison
Compare NHTC & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- ESLA
- Stock Information
- Founded
- NHTC 1988
- ESLA 2021
- Country
- NHTC United States
- ESLA United States
- Employees
- NHTC N/A
- ESLA N/A
- Industry
- NHTC Diversified Commercial Services
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NHTC Miscellaneous
- ESLA Health Care
- Exchange
- NHTC Nasdaq
- ESLA Nasdaq
- Market Cap
- NHTC 56.0M
- ESLA 48.9M
- IPO Year
- NHTC 1995
- ESLA N/A
- Fundamental
- Price
- NHTC $4.23
- ESLA $1.26
- Analyst Decision
- NHTC
- ESLA Strong Buy
- Analyst Count
- NHTC 0
- ESLA 1
- Target Price
- NHTC N/A
- ESLA $16.00
- AVG Volume (30 Days)
- NHTC 15.2K
- ESLA 115.6K
- Earning Date
- NHTC 10-29-2025
- ESLA 11-20-2025
- Dividend Yield
- NHTC 18.96%
- ESLA N/A
- EPS Growth
- NHTC N/A
- ESLA N/A
- EPS
- NHTC 0.03
- ESLA N/A
- Revenue
- NHTC $42,087,000.00
- ESLA N/A
- Revenue This Year
- NHTC N/A
- ESLA N/A
- Revenue Next Year
- NHTC N/A
- ESLA N/A
- P/E Ratio
- NHTC $141.62
- ESLA N/A
- Revenue Growth
- NHTC N/A
- ESLA N/A
- 52 Week Low
- NHTC $4.02
- ESLA $0.63
- 52 Week High
- NHTC $6.79
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- NHTC 34.75
- ESLA 54.90
- Support Level
- NHTC $4.30
- ESLA $1.12
- Resistance Level
- NHTC $4.45
- ESLA $1.48
- Average True Range (ATR)
- NHTC 0.12
- ESLA 0.13
- MACD
- NHTC -0.03
- ESLA 0.01
- Stochastic Oscillator
- NHTC 4.07
- ESLA 31.82
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.